![](/img/cover-not-exists.png)
Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor
Martins, Leila R., Perera, Yasser, Lúcio, Paulo, Silva, Maria G., Perea, Silvio E., Barata, João T.Volume:
5
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.1513
Date:
January, 2014
File:
PDF, 847 KB
english, 2014